Elevated Health review

Take a quarter dose here and you pay what a full dose costs — Elevated says so itself, in one sentence: "Same price at every dose." The gap between the drug you buy and the drug you use is yours to absorb. Credit where it is due, because this is a candid provider. It prints the first-order rate and the standing rate side by side rather than hiding the step-up, publishes the whole prepay ladder for both molecules with the per-month equivalent spelled out, and states a specific potency-testing cadence and tolerance instead of gesturing at quality. Three things will cost you if you misread them. The figure on the product cards is the twelve-month prepay rate, and month to month is well over half as much again. Those cards disagree with each other across pages, so the advertised figure you saw depends on where you landed. And the standing rate carries an asterisk whose footnote does not exist on the page.

Vs median

$127/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

Elevated Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Elevated Health sells compounded semaglutide and compounded tirzepatide as once-weekly self-injections with medication and injection supplies inside one monthly figure, and states its pricing basis in a single sentence: "No membership fees. Same price at every dose. Medication and injection supplies included." It publishes the standing month-to-month rate, the first-order rate and a full three-, six- and twelve-month prepay ladder for both molecules. Its quality claims are unusually specific — batches "rigorously third-party tested in FDA- and DEA-registered labs", with a potency test performed every three to six months confirming ±10% of label. No compounding pharmacy is named and no state list is published.

ONE PRICE AT EVERY DOSE IS THE STRUCTURE THIS SITE EXISTS TO FLAG. A patient deliberately holding at 0.25 mg/week pays the same $296 as one at the top of the range. Elevated is candid about it, and candor does not change the arithmetic

• The advertised "Starting at $187/mo" is the twelve-month prepay rate. The month-to-month rate is $296 — 58% higher
• The two treatment pages disagree with each other: /semaglutide advertises "Compounded Semaglutide Starting at $196 per month" while /tirzepatide advertises "Compounded Semaglutide Starting at $187 per month" for the same product
• "$296 for a 1-month supply*" carries an asterisk with no footnote anywhere on the page — the qualifier it points to is not published
• No week count is published, so what a "1-month supply" contains is never stated
• No compounding pharmacy is named — "compounded at pharmacies licensed in all 50 states" is a pharmacy claim, not a statement of where a reader can be treated
• The footer legal menu is labeled "HIPPA"
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Elevated Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan